Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Spelman

Showing results (121-130 of 266) with videos related to

Pageof 27
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 15, 2020
Clinical outcomes in patients who discontinue natalizumab therapy after 2 years in the Tysabri<sup>®</sup> Observational Program (TOP)Helmut Butzkueven, Maria Trojano, Ludwig Kappos, et al.
ANZ Journal of Surgery|February 11, 2023
Oncologic outcomes in myxofibrosarcomas: the role of a multidisciplinary approach and surgical resection marginsIsaac Rhee, Benedetta Spazzoli, Jarrad Stevens, et al.
Critical Reviews in Oncology/Hematology|September 22, 2023
Infections in haematology patients treated with CAR-T therapies: A systematic review and meta-analysisGemma K Reynolds, Beatrice Sim, Tim Spelman, et al.
Plos One|June 30, 2016
Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective CohortJoseph S Doyle, Jason Grebely, Tim Spelman, et al.
Plos One|December 10, 2016
Quantifying Adaptive and Innate Immune Responses in HIV-Infected Participants Using a Novel High Throughput AssayMichelle K Yong, Paul U Cameron, Tim Spelman, et al.
JAMA Neurology|August 16, 2021
Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis: Data From 2 Different National StrategiesTim Spelman, Melinda Magyari, Fredrik Piehl, et al.
Archives of Public Health = Archives Belges De Sante Publique|September 26, 2024
Coping with COVID-19: a prospective cohort study on young Australians' anxiety and depression symptoms from 2020-2021Ana Orozco, Alexander Thomas, Michelle Raggatt, et al.
Journal of Translational Medicine|January 28, 2015
The CD14 C-260T single nucleotide polymorphism (SNP) modulates monocyte/macrophage activation in treated HIV-infected individualsReena Rajasuriar, Yong Yean Kong, Reshika Nadarajah, et al.
Communicable Diseases Intelligence Quarterly Report|September 5, 2008
Enhanced case detection for newly acquired hepatitis C infection: epidemiological findings and health service implicationsRebecca Guy, Darshini Devadason, Megan Lim, et al.
Medicine|August 7, 2016
Genetic polymorphisms in the CD14 gene are associated with monocyte activation and carotid intima-media thickness in HIV-infected patients on antiretroviral therapyYean K Yong, Esaki M Shankar, Clare L V Westhorpe, et al.
Pageof 27

Showing results (121-130 of 266) with videos related to

Sort By:
Pageof 27
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 15, 2020
Clinical outcomes in patients who discontinue natalizumab therapy after 2 years in the Tysabri<sup>®</sup> Observational Program (TOP)Helmut Butzkueven, Maria Trojano, Ludwig Kappos, et al.
ANZ Journal of Surgery|February 11, 2023
Oncologic outcomes in myxofibrosarcomas: the role of a multidisciplinary approach and surgical resection marginsIsaac Rhee, Benedetta Spazzoli, Jarrad Stevens, et al.
Critical Reviews in Oncology/Hematology|September 22, 2023
Infections in haematology patients treated with CAR-T therapies: A systematic review and meta-analysisGemma K Reynolds, Beatrice Sim, Tim Spelman, et al.
Plos One|June 30, 2016
Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective CohortJoseph S Doyle, Jason Grebely, Tim Spelman, et al.
Plos One|December 10, 2016
Quantifying Adaptive and Innate Immune Responses in HIV-Infected Participants Using a Novel High Throughput AssayMichelle K Yong, Paul U Cameron, Tim Spelman, et al.
JAMA Neurology|August 16, 2021
Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis: Data From 2 Different National StrategiesTim Spelman, Melinda Magyari, Fredrik Piehl, et al.
Archives of Public Health = Archives Belges De Sante Publique|September 26, 2024
Coping with COVID-19: a prospective cohort study on young Australians' anxiety and depression symptoms from 2020-2021Ana Orozco, Alexander Thomas, Michelle Raggatt, et al.
Journal of Translational Medicine|January 28, 2015
The CD14 C-260T single nucleotide polymorphism (SNP) modulates monocyte/macrophage activation in treated HIV-infected individualsReena Rajasuriar, Yong Yean Kong, Reshika Nadarajah, et al.
Communicable Diseases Intelligence Quarterly Report|September 5, 2008
Enhanced case detection for newly acquired hepatitis C infection: epidemiological findings and health service implicationsRebecca Guy, Darshini Devadason, Megan Lim, et al.
Medicine|August 7, 2016
Genetic polymorphisms in the CD14 gene are associated with monocyte activation and carotid intima-media thickness in HIV-infected patients on antiretroviral therapyYean K Yong, Esaki M Shankar, Clare L V Westhorpe, et al.
Pageof 27